Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-22-260662
Filing Date
2022-10-11
Accepted
2022-10-11 16:30:54
Documents
2
Group Members
ALEXANDER J. DENNER, PH.D.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d399645dsc13da.htm SC 13D/A 42895
2 EX-3 d399645dex3.htm EX-3 10009
  Complete submission text file 0001193125-22-260662.txt   54689
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Subject) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-52399 | Film No.: 221304382
SIC: 2834 Pharmaceutical Preparations

Mailing Address 660 STEAMBOAT ROAD GREENWICH CT 06830
Business Address 660 STEAMBOAT ROAD GREENWICH CT 06830 203-302-2330
Sarissa Capital Management LP (Filed by) CIK: 0001577524 (see all company filings)

EIN.: 900924432 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A